GlaxoSmithKline Intellectual Property Development Limited
发明人:
FRANCIS, Christopher John,GAO, Hua-Xin,YANAMANDRA, Niranjan,LI, Yufeng
申请号：
HK18108033
公开号：
HK1249410A1
申请日:
2018.06.22
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
Disclosed herein are combinations of an OX40 modulator and a TLR4 modulator, pharmaceutical compositions thereof, uses thereof, and methods of treatment comprising administering said combination, including uses in cancer.
